Point-of-Care Haemostasis Monitoring describes rotational thromboelastography (ROTEM) and thromboelastography (TEG), which measure the viscoelastic properties of whole blood clotting in real time. The shape of the clotting curve is most important. ROTEM and TEG have different names for the same measurements and are not interchangeable. The goal of point-of-care coagulation monitoring is to reduce blood product transfusion by targeting specific clotting factor deficiencies. It has been recommended for cardiac and obstetric patients but not trauma patients due to lack of evidence. Two case studies show ROTEM traces of severely coagulopathic trauma patients and the impact of targeted